Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D001859:Bone Neoplasms / Q000188:drug therapy / Q000628:therapy*; D002648:Child; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000532:radiotherapy / Q000628:therapy*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011407:Propane / Q000009:adverse effects / Q000627:therapeutic use; D011830:Radiation Effects; D012509:Sarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012867:Skin / Q000528:radiation effects
D000970:Antineoplastic Agents; D010879:Piperazines; D011407:Propane